Cost effectiveness in context

Editorial

Clyde B Schechter. J Clin Oncol. 2007.

. 2007 Feb 20;25(6):609-10.

doi: 10.1200/JCO.2006.08.8278.

No abstract available

Comment on

What is the most cost-effective population-based cancer screening program for Chinese women?
Woo PP, Kim JJ, Leung GM. Woo PP, et al. J Clin Oncol. 2007 Feb 20;25(6):617-24. doi: 10.1200/JCO.2006.06.0210. J Clin Oncol. 2007. PMID: 17308266

A quest for quality and economic effectiveness throughout the continuum of breast care.
La Fargue MM, Coleman C. La Fargue MM, et al. Breast. 2010 Aug;19(4):251-2. doi: 10.1016/j.breast.2010.03.020. Epub 2010 Apr 13. Breast. 2010. PMID: 20392641 No abstract available.
[Mammography screening in Germany: how, when and why?].
Bick U. Bick U. Rofo. 2006 Oct;178(10):957-69. doi: 10.1055/s-2006-926959. Rofo. 2006. PMID: 17021975 Review. German.
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Okonkwo QL, et al. J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292. Epub 2008 Sep 9. J Natl Cancer Inst. 2008. PMID: 18780864
Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM. Wong IO, et al. Hong Kong Med J. 2010 Jun;16 Suppl 3:38-41. Hong Kong Med J. 2010. PMID: 20601733 No abstract available.
Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspective.
Bines J, Eniu A. Bines J, et al. Cancer. 2008 Oct 15;113(8 Suppl):2353-8. doi: 10.1002/cncr.23837. Cancer. 2008. PMID: 18837028 Review.